miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells is a paper indexed in ScholarIQ from OpenAlex.
How many citations does miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells have?
miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells has 718 citations in the OpenAlex counts ScholarIQ stores.
When was miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells published?
miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells has 2008 year in the ScholarIQ index.
What is the open-access status of miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells?
miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells has bronze oa status in the ScholarIQ index.
What is the DOI of miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells?
The DOI for miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells is on the source record.
What is the PMID of miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells?
The PMID for miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells is on the source record.
What is the OpenAlex record for miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells?
The OpenAlex for miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells is on the source record.